1 not yet recruiting. 1 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 1 | Not yet recruiting 1 |
Follow Kent Wellish MD: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Treating Corneal Thinning Conditions With CCL Vario Riboflavin (CXL) Riboflavin - Keratoconus, Unstable | Early Phase 1 | Not yet recruiting | Kent Wellish MD | 600 | 2021-06-30 | 2021-05-25 |
Keratoconus (1)
Riboflavin (1) · Ultraviolet Rays (1)